Connexion
Connexion
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Inscription
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SEAGEN INC.

(SGEN)
  Rapport
Temps Différé Nasdaq  -  22:00 28/11/2022
121.22 USD   -1.80%
25/11Le point hebdo de l'investisseur : Je préfère quand c'est un peu trop plus moins calme
ZB
21/11Seagen Inc. : Truist Securities conserve son opinion neutre
ZM
15/11Vente d'initiés : Seagen
MT
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Jours
:
Heures
:
Minutes
:
Secondes
Actualités dans d'autres langues sur SEAGEN INC.
26/11Börsen-Update der Woche : Ruhe vor dem Sturm
26/11La rassegna settimanale di Borsa : Preferisco quando c'..
26/11Wekelijks beursoverzicht : Toch liever iets minder kalm
25/11Weekly market update : The calm before the storm
22/11Mirati attracts fresh takeover interest - Bloomberg News
21/11Merck to buy Imago for $1.35 bln to broaden portfolio of blood disorder drugs
21/11Insider Sell: Seagen
18/11Seagen Inc. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial S..
15/11Insider Sell: Seagen
15/11Immunogen's $6,220 ovarian cancer drug to be shipped within days
11/11Seagen to Highlight New Research from its Diverse Pipeline of Targeted Cancer Therapy C..
10/11Seagen Gets FDA Nod for Adcetris to Treat Blood Cancer in Children
10/11Seagen Announces U.S. FDA Approval of New Indication for ADCETRIS® (brentuximab vedotin..
10/11Seagen Inc. Announces U.S. FDA Approval of New Indication for Adcetris® (Brentuximab Ve..
10/11Seagen Appoints David Epstein as Chief Executive Officer
10/11Seagen to Highlight New Research from its Diverse Pipeline of Targeted Cancer Therapy C..
10/11Seagen Inc. : Change in Directors or Principal Officers (form 8-K)
10/11Seagen Inc. Announces Board Appointments
10/11Seagen Inc. Announces CEO Changes
10/11Seagen Appoints Sandra M. Swain, M.D., to Board of Directors
10/11Seagen Names David R. Epstein as Chief Executive Officer and Director
28/10Seagen : Earnings Document
27/10SEAGEN INC. Management's Discussion and Analysis of Financial Condition and Results of..
27/10Seagen Reports Improved Q3 Results, Boosts 2022 Revenue Forecast
27/10Transcript : Seagen Inc., Q3 2022 Earnings Call, Oct 27, 2022
27/10Seattle Genetics : Q3 Earnings Snapshot
27/10Earnings Flash (SGEN) SEAGEN Reports Q3 Revenue $510.3M
27/10Seagen Reports Third Quarter 2022 Financial Results
27/10Seagen Inc. Revises Revenue Guidance for the Full Year of 2022
27/10Seagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septem..
20/10Insider Sell: Seagen
12/10ANALYSEN DES TAGES von Dow Jones Newswires (12.10.2022)
12/10MarketScreener's World Press Review : October 12, 20..
12/10North American Morning Briefing: Caution Likely -2-
06/10Seagen to Host Conference Call and Webcast Discussion of Third Quarter 2022 Financial R..
28/09Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
28/09Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
28/09Zai Lab Strikes Licensing Deal with Nasdaq-listed Seagen for Cervical Cancer Drug
27/09Zai Lab Signs Exclusive Collaboration, License Agreement With Seagen to Develop, Commer..
27/09Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
27/09Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
26/09Sector Update: Health Care Stocks Fall on Monday
26/09Sector Update: Health Care
26/09Top Midday Gainers
26/09Seagen, Lava Therapeutics Sign License Agreement for Pre-Clinical Asset Targeting Solid..
26/09Seagen and LAVA Therapeutics Announce Exclusive Worldwide License Agreement to Advance ..
26/09Seagen and LAVA Therapeutics Announce Exclusive Worldwide License Agreement to Advance ..
20/09US Stocks Fall Tuesday as Fed Policy Meeting Begins
20/09US Stocks Fall Tuesday as Bond Yields Climb; Fed Policy Meeting Begins
20/09Seagen Announces TUKYSA in Combination with Trastuzumab Granted Priority Review by FDA ..
19/09Seagen Says US FDA Grants Priority Review to Tukysa Plus Trastuzumab for HER2-Positive ..
19/09Seagen Announces TUKYSA® (tucatinib) in Combination with Trastuzumab Granted Priority R..
19/09Seagen Inc. Announces TUKYSA® in Combination with Trastuzumab Granted Priority Review b..
19/09Seagen Gets FDA Priority Review of Tukysa in Colorectal Cancer
14/09Transcript : Seagen Inc. Presents at Morgan Stanley 20th Annual Global Health..
12/09Seagen, Merck, Astellas Release Data From Trial of Padcev, Keytruda to Treat Bladder Ca..
12/09Seagen, Astellas and Merck Announce Results of Clinical Trial Investigating Padcev with..
12/09Astellas, Seagen and Merck Announce Results of Clinical Trial Investigating PADCEV(R) (..
08/09Seagen to Highlight Research in Urothelial and Colorectal Cancers at 2022 European Soci..
08/09Seagen to Highlight Research in Urothelial and Colorectal Cancers At 2022 European Soci..
07/09Seagen to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
26/08Sector Update: Health Care Losses Accelerate Just Before Friday Close
26/08Market Chatter: Merck's Talks to Buy Seagen Reportedly Stall Due to Price
26/08Sector Update: Health Care Stocks Sinking with Broader Friday Markets
26/08Sector Update: Health Care
26/08Merck’s Reportedly Talks to Acquire Seagen Hit Snag, Threatening Mega Pharma Deal
26/08Merck's Talks to Buy Seagen Reportedly Stall Due to Price
26/08Dpa-AFX-Überblick: UNTERNEHMEN vom 26.08.2022 - 15.15 Uhr
26/08Aktien New York Ausblick: Zurückhaltung vor Powell-Rede in Jack..
26/08EN DIRECTO DESDE LOS MERCADOS: Neinor Homes, Open Text, ED..
26/08Bolsa de Madrid: Jerome, ¡un discurso! Jerome, ¡un discurso!
26/08Gespräche zur Milliardenübernahme von Seagan durch Merck & Co angeblich auf Eis
26/08Merck & Co.'s Seagen Deal Talks Said to Stall on Terms
25/08ANALYSEN DES TAGES von Dow Jones Newswires (25.08.2022)
17/08North American Morning Briefing: Investors Seek -2-
15/08China blues
15/08Analyst recommendations: Coca-Cola, Dollar General, Comcast, Del..
15/08Japan Index Rallies on Upbeat Economic Reports; Daiichi Sankyo Soars 14% on Legal Victo..
15/08Nikkei hits over 7-month high on Wall Street optimism, robust earnings
15/08Japanese shares rise on Wall Street optimism, strong earnings
15/08Daiichi Sankyo Shares Gain After It Wins Dispute Over Cancer Drug Technology
12/08Seagen : Statement on Outcome of Daiichi Sankyo Arbitration - Form 8-K
12/08Seagen Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
12/08Seagen Loses Arbitration Against Daiichi Sankyo; Sees No Impact on Existing Business
12/08Seagen loses arbitration against Daiichi Sankyo over drug technology
12/08Seagen loses arbitration ruling against Daiichi Sankyo
12/08Seagen Statement on Outcome of Daiichi Sankyo Arbitration
28/07SEAGEN INC. Management's Discussion and Analysis of Financial Condition and Results of..
28/07Transcript : Seagen Inc., Q2 2022 Earnings Call, Jul 28, 2022
28/07Seagen Q2 Net Loss Widens, Revenue Rises; Increases 2022 Revenue Guidance
28/07Seattle Genetics : Q2 Earnings Snapshot
28/07Seagen : Reports Second Quarter 2022 Financial Results - Form 8-K
28/07Earnings Flash (SGEN) SEAGEN Reports Q2 Revenue $497.5M
28/07Earnings Flash (SGEN) SEAGEN Reports Q2 Revenue $497.5M
28/07Seagen Reports Second Quarter 2022 Financial Results
28/07Seagen Inc. Revises Earnings Guidance for the Year 2022
28/07Seagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 3..
27/07Astellas and Seagen Announce Positive Topline Results For PADCEV (enfortumab vedotin-ej..
27/07It's Fed day - What's in the bag for September?
27/07Analyst recommendations: Meta Platforms, McDonald's, Raytheon Te..
Prochain événement sur SEAGEN INC.